News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation

CareDx (NASDAQ:CDNA) had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings.

CareDx (NASDAQ:CDNA) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.

CareDx to Participate in Upcoming Investor Conferences

CareDx (NASDAQ:CDNA) was upgraded by analysts at Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.

11/4/2025

04:05 pm

CDNA

13.8%

BEAT

8/6/2025

04:01 pm

CDNA

-7.9%

BEAT

4/30/2025

04:05 pm

CDNA

-10.7%

BEAT

2/26/2025

04:05 pm

CDNA

-0.2%

BEAT

Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam

Form SCHEDULE 13G CareDx, Inc. Filed by: BAMCO INC /NY/

Form 4 CareDx, Inc. For: Nov 07 Filed by: Novack Jeffrey Adam

Form 4 CareDx, Inc. For: Nov 06 Filed by: Novack Jeffrey Adam

Form 144 CareDx, Inc. Filed by: Novack Jeffrey Adam

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}